Zaltoprofen

DB06737InvestigationalSmall molecule

A non-steroidal anti-inflammatory drug approved for use in Japan in 1993.

Mechanism: Pharmacologically active on Prostaglandin G/H synthase 1, Peroxisome proliferator-activated receptor gamma, and Prostaglandin G/H synthase 2
Curator reviewed
Formula / weight: C₁₇H₁₄O₃S · 298.36 g/mol (avg)
Code names: CN-100 · ZC 102

Resolves to

Compound

Structure

InChIKeyMUXFZBHBYYYLTH-UHFFFAOYSA-NSMILESCC(C(O)=O)C1=CC=C2SC3=C(C=CC=C3)C(=O)CC2=C1

Targets

What you can answer from here — as of July 03, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1,565Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with Zaltoprofen, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.